Investors
Spark
SPARK Ventures
SPARK Ventures is the leading quoted early-stage venture capital company in Europe. It manages over £200 million on behalf of major institutional investors, leading UK universities, and two quoted venture capital trusts. SPARK invests in entrepreneurs to create dynamic businesses in the technology, media, telecoms and healthcare & life sciences sectors. As well as capital, it brings a wealth of experience of developing high growth companies from early stage through to IPO or trade sale, adding value to its investments through active support and strategic direction.

For further information, please visit: www.sparkventures.com


HBM
HBM BioVentures
As a venture capital company, HBM BioVentures is invested globally in some 40 mature emerging companies in the biotechnology/human medicine, diagnostics and medical technology sectors. The primary products of HBM BioVentures’ portfolio companies are either at an advanced stage of development or already available on the market. The company focuses on unquoted emerging companies, with two-thirds invested in private companies that offer high value creation potential. This has enabled HBM BioVentures to carve out a unique and distinctive market position. HBM BioVentures has a broad shareholder base and is listed on the Swiss Stock Exchange (SIX: HBMN).

For further information, please visit: www.hbmbioventures.com


AGF
idinvest Partners
With €2.7 billion under management, IDinvest Partners (formerly AGF Private Equity) is a major actor in European venture capital and has invested in more than 80 companies to date. It has a regular, durable investment capacity investing more than €50 million each year in young businesses with strong potential. In all, the venture capital team manages more than €600 million. In September 2010, IDInvest Partners entered into an agreement with Kurma Life Sciences Partners under which Kurma manages the €87 million of biotechnology investments within the IDInvest porftfolio.

For further information, please visit: www.idinvestpartners.com and www.kurmabiofund.com


Contact Details
Vivacta Limited
100 Guillat Avenue
Kent Science Park
Sittingbourne
Kent
ME9 8GU
United Kingdom

Tel: +44 (0)1795 419400
Fax:+44 (0)1795 419401
Email enquiries to:
enquiries@vivacta.com